A randomized, double-blind phase 3 study of gemcitabine plus AG-013736 versus gemcitabine plus placebo for the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer

  • Palmer, Daniel (Principal Investigator)

Project Details

Short titleA randomized, double-blind phase 3 study of gemcitabine plus AG-013736 versus gemcitabine plus placebo for the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer
StatusFinished
Effective start/end date1/03/0831/12/11

Funding

  • Queen Elizabeth Hospital Birmingham